Abstract
Diabetic retinopathy (DR) is the most common microvascular complication of diabetes and the leading cause of blindness in industrialized countries. Oxidative stress plays an important role in the development of microangiopathic complications in diabetes. Manganese superoxide dismutase (MnSOD) is a key mitochondrial antioxidant enzyme in the cellular defense against agents that induce oxidative stress. The aim of the present study was to assess whether the MnSOD A16V (C47T) polymorphism is associated with Diabetic retinopathy in northern Iran. 140 patients with Diabetic retinopathy and 140 healthy individuals, aged 30 to 75 years old, participated in this study. For genotyping of the MnSOD A16V polymorphism the polymerase chain reaction—restriction fragment length polymorphism (PCR-RFLP) method was used. The prevalence of genotype frequencies AA, AV, VV in Diabetic retinopathy subjects were 5.71, 71.43 and 22.86%, respectively, while in controls they were 21.43, 38.57 and 40%, respectively. A significantly increased frequency of the AV genotype was observed in patients as compared with controls (OR = 6.94, 95% CI = 2.98–16.20, P < 0.0001). In conclusion, it is suggested that the MnSOD A16V polymorphism may be associated with the risk of Diabetic retinopathy in northern Iran. However, larger population-based studies are needed for clarifying the relation between Diabetic retinopathy and the MnSOD A16V polymorphism.
Similar content being viewed by others
References
Resnikoff S., Pascolini D., Etya’ale D., Kocur I., Pararajasegaram R., Pokharel G.P., Mariotti S.P. 2004. Global data on visual impairment in the year 2002. Bull. World Health Org. 82, 844–851.
Roy M.S., Klein R., O’Colmain B.J., Klein B.E., Moss S.E., Kempen J.H. 2004. The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch. Ophthalmol. 122, 546–551.
Mitchell P., Foran S., Wong T.Y., Chua B., Patel I., Ojami E., Foran J. 2008. Guidelines for the Management of Diabetic Retinopathy. Canberra, Australia: National Health and Medical Research Council.
Chun M.Y., Hwang H.S., Cho H.Y., Chun H.J., Woo J.T., Lee K.W., Nam M.S., Baik S.H., Kim Y.S., Park Y. 2010. Association of vascular endothelial growth factor polymorphisms with nonproliferative and proliferative diabetic retinopathy. J. Clin. Endocrinol. Metab. 95, 3547–3551.
Uthra S., Raman R., Mukesh B.N., Kumari R., Sharma T., McCarty C.A., Kumaramanickavel G. 2008. Genetics of diabetic retinopathy. Int. J. Hum. Genet. 8, 155–159.
Cai J., Boulton M. 2002. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye. 16, 242–260.
Ferrara N., Davis-Smyth T. 1997. The biology of vascular endothelial growth factor. Endocr. Rev. 18, 4–25.
Giugliano D., Ceriello A., Paolisso G. 1996. Oxidative stress and diabetic vascular complications. Diabetes Care. 19, 257–267.
Bag A., Bag N. 2008. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review. Cancer Epidemiol. Biomarkers Prev. 17, 3298–3305.
Baker A.M., Oberley L.W., Cohen M.B. 1997. Expression of antioxidant enzymes in human prostatic adenocarcinoma. Prostate. 32, 229–233.
Wan X.S., Devalaraja M.N., St. Clair D.K. 1994. Molecular structure and organization of the human manganese superoxide dismutase gene. DNA Cell Biol. 13, 1127–1136.
Rosenblum J.S., Gilula N.B., Lerner R.A. 1996. On signal sequence polymorphisms and diseases of distribution. Proc. Natl. Acad. Sci. U. S. A. 93, 4471–4473.
Sutton A., Khoury H., Prip-Buus C., Cepanec C., Pessayre D., Degoul F. 2003. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenet. Genomics. 13, 145–157.
Sutton A., Imbert A., Igoudjil A., Descatoire V., Cazanave S., Pessayre D., Degoul F. 2005. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet. Genomics. 15, 311–319.
Arsova-Sarafinovska Z., Matevska N., Petrovski D., Banev S., Dzikova S., Georgiev V., Sikole A., Sayal A., Aydin A., Suturkova L. 2008. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer. Cell Biochem. Funct. 26, 771–777.
Nakanishi S., Yamane K., Ohishi W., Nakashima R., Yoneda M., Nojima H., Watanabe H., Kohno N. 2008. Manganese superoxide dismutase Ala16Val polymorphism is associated with the development of type 2 diabetes in Japanese-Americans. Diabetes Res. Clin. Pract. 81, 381–385.
Brownlee M. 2005. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 54, 1615–1625.
Kowluru R.A., Chan P.-S. 2007. Oxidative stress and diabetic retinopathy. Exp. Diabetes Res. 2007, ID 43603.
Kowluru R.A., Kowluru V., Xiong Y., Ho Y.S. 2006. Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radic. Biol. Med. 41, 1191–1196.
Petrovi M.G., Cilenšek I., Petrovi D. 2008. Manganese superoxide dismutase gene polymorphism (V16A) is associated with diabetic retinopathy in Slovene (Caucasians) type 2 diabetes patients. Dis. Markers. 24, 59–64.
Hovnik T., Dolžan V., Bratina N.U., Podkrajšek K.T., Battelino T. 2009. Genetic polymorphisms in genes encoding antioxidant enzymes are associated with diabetic retinopathy in type 1 diabetes. Diabetes Care. 32, 2258–2262.
Kangas-Kontio T., Vavuli S., Kakko S., Penna J., Savolainen E.-R., Savolainen M., Liinamaa M.J. 2009. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy. Br. J. Ophthalmol. 93, 1401–1406.
Kowalski M., Bielecka-Kowalska A., Oszajca K., Eusebio M.O., Jaworski P., Bartkowiak J., Szemraj J. 2010. Manganese superoxide dismutase (MnSOD) gene (Ala-9Val, Ile58Thr) polymorphism in patients with age-related macular degeneration (AMD). Med. Sci. Monit. 16, 190–196.
Woodson K., Tangrea J.A., Lehman T.A., Modali R., Taylor K.M., Snyder K., Taylor P.R., Virtamo J., Albanes D. 2003. Manganese superoxide dismutase (MnSOD) polymorphism, α-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland). Cancer Causes Control. 14, 513–518.
Olson S., Carlson M., Ostrer H., Harlap S., Stone A., Winters M., Ambrosone C. 2004. Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer. Gynecol. Oncol. 93, 615–620.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Molekulyarnaya Biologiya, 2015, Vol. 49, No. 1, pp. 114–118.
The article is published in the original.
Rights and permissions
About this article
Cite this article
Haghighi, S.F., Salehi, Z., Sabouri, M.R. et al. Polymorphic variant of MnSOD A16V and risk of diabetic retinopathy. Mol Biol 49, 99–102 (2015). https://doi.org/10.1134/S0026893315010057
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893315010057